CVE-2017-13747

Public Exploit

Description

There is a reachable assertion abort in the function jpc_floorlog2() in jpc/jpc_math.c in JasPer 2.0.12 that will lead to a remote denial of service attack.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 1.64% Top 20%
Vendor Advisory gentoo.org Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/100514 vdb entry third party advisory
https://bugzilla.redhat.com/show_bug.cgi?id=1485282 issue tracking exploit third party advisory
https://security.gentoo.org/glsa/201908-03 third party advisory vendor advisory
https://lists.fedoraproject.org/archives/list/package-announce%40lists.fedoraproject.org/message/UPOVZTSIQPW2H4AFLMI3LHJEZGBVEQET/ vendor advisory
https://lists.fedoraproject.org/archives/list/package-announce%40lists.fedoraproject.org/message/N4ALB4SXHURLVWKAOKYRNJXPABW3M22M/ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2017-13747?
CVE-2017-13747 has been scored as a high severity vulnerability.
How to fix CVE-2017-13747?
To fix CVE-2017-13747, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-13747 being actively exploited in the wild?
It is possible that CVE-2017-13747 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.